August 28, 2026
4:16 am

What Is a Life Expectancy Provider?

A life expectancy provider is an independent medical underwriting firm that reviews an insured’s medical records and produces a report estimating how many more months that person is likely to live, expressed as a distribution rather than a date. They do not buy policies, do not sell anything to consumers, and never contact the insured. They are hired by the parties on the buying side, and their number is the largest single input into what a policy is worth.

That is why a seller should understand them. Almost every variable in a settlement is fixed – the face amount, the premium, the carrier. The life expectancy estimate is the one input that is produced by judgment, that can differ between firms looking at the same records, and that quietly determines whether an offer is $60,000 or $110,000.

This page is organized around the decisions a household actually gets to make once an LE provider enters the picture, because most articles describe the industry and leave the reader with nothing to do. Pine Lake Legacy provides education and a free policy review only.

In This Article

What They Produce, and What the Number Actually Means
Who These Firms Are, and Why the Roster Matters
Decision One: Whether to Sign the Records Release, and How Broadly
Decision Two: Whether to Ask How Many Reports Were Ordered, and Which Was Used
Decision Three: What to Do When Health Changes Mid-Process
Decision Four: What Happens If You Outlive the Estimate
Terms It Is Confused With
Frequently Asked Questions

What They Produce, and What the Number Actually Means

An LE report is not a prediction of a death date and does not claim to be. It gives a mortality assessment: typically a mean and a median life expectancy in months, and a mortality multiplier expressed as a percentage of a standard base mortality table. A multiplier of 200 percent means the insured is assessed as roughly twice as likely to die in a given period as the base table’s population at the same age and sex.

The base table is usually a Society of Actuaries Valuation Basic Table, with the 2015 VBT the common reference in recent years – see what the VBT is. The multiplier, not the headline month count, is what buyers actually model, because it produces a monthly survival curve rather than a single date.

Note the mean and median differ, often by several months, and which one a buyer uses changes the price. That is a fair question to ask.

It helps to see how the number turns into money. A buyer projects, month by month, the probability the insured is still living, the premium that must be paid to keep the policy in force that month, and the probability the death benefit is collected. Those cash flows are then discounted back to today. Lengthen the estimate by two years on a policy with a $14,000 annual premium and the buyer has added roughly $28,000 of projected outlay while pushing the payout further away – which is why a modest change in months can move an offer by tens of thousands of dollars on a mid-sized policy.

That is also why two honest professionals can look at the same file and disagree without either being wrong. There is no scoreboard that settles it until decades of outcomes accumulate, and by then the policies in question have long since paid.

Who These Firms Are, and Why the Roster Matters

A small number of firms dominate. Names that have been active and widely cited in the sector for years include Fasano Associates, AVS Underwriting, ITM TwentyFirst (long known as 21st Services) and Predictive Resources. The roster changes through mergers and rebranding, so confirm current names rather than relying on a list, including this one.

Concentration matters because these firms are not interchangeable. Each has its own underwriting manual, its own debits and credits for particular conditions, and its own calibration history. The same file can produce materially different estimates at two firms, which is precisely why buyers often order more than one report.

There is a real, checkable episode that shows how much this matters. In 2008 a leading LE firm recalibrated its methodology and lengthened its estimates substantially – reported in the trade press at roughly twenty percent – after concluding that earlier assumptions had been too aggressive. Longer estimates mean more projected premiums and a later payout, so offers across the market fell and portfolios were repriced. Nothing about the insured people changed. That is the clearest illustration available of how much of the price rests on a judgment.

Decision One: Whether to Sign the Records Release, and How Broadly

Nothing happens without a HIPAA authorization. The LE provider cannot request records, and without records there is no report and no offer. This is the first real decision, and it is a genuine one – some people decide the medical privacy cost is not worth an exploratory quote, and that is a legitimate answer.

If you do sign, read the scope. A well-drafted authorization names the specific providers or record types, states an expiration date, and says who may receive the information. You are entitled to ask that it be limited in time and to revoke it prospectively. Do not sign an open-ended release that names no expiration. See what a HIPAA authorization should contain.

Practical note: incomplete records are the most common cause of a disappointing estimate. Underwriters cannot credit a condition they cannot see, and they generally will not assume a favorable fact. If a specialist holds the records that best document the insured’s situation, make sure that practice is on the list.

Question to ask	Why it changes the outcome	Ask whom
How many LE reports were ordered?	Two reports averaged versus one changes the price	Your broker, in writing
Which firms produced them?	Different manuals produce different estimates	Your broker
Mean or median, and what multiplier?	These differ by months and drive the model	Your broker
How old are the medical records?	Stale or incomplete records lower estimates of severity	Your broker and physicians
Is the HIPAA release time-limited?	Controls how long records can be pulled	Read the authorization
Who pays for the reports?	Normally the buyer or broker, not you	Your broker

Decision One: Whether to Sign the Records Release, and How Broadly

Decision Two: Whether to Ask How Many Reports Were Ordered, and Which Was Used

Buyers commonly order two independent reports and price from the average, or from the longer of the two if their mandate is conservative. Which convention applies changes the offer directly, and the seller is rarely told unless they ask.

Ask three questions of your broker in writing. How many LE reports were obtained. Which firms produced them. And which figure the offer was priced from – the mean, the median, or a blend. None of these are secrets, and a broker who will not answer is telling you something. Read what an LE report contains so the answers are meaningful.

The related decision is whether to ask for a copy. Some firms restrict redistribution of the report itself, but a summary of the months and multiplier is normally obtainable. If you are being asked to accept a life-changing decision priced off a document you have never seen, asking for it is reasonable.

Decision Three: What to Do When Health Changes Mid-Process

Life expectancy estimates go stale. Most buyers treat a report as usable for a limited window – commonly around a year – and will require a refresh if the file sits.

The direction of the change is worth understanding without flinching. If health has genuinely improved since the records were pulled, an updated report will lengthen the estimate and the offer will come down, because the buyer projects more years of premium payments before any payout. That is not a trick; it is arithmetic. See why better health produces a lower offer.

If health has declined and there are newer records documenting it, the reverse is true, and an update may be worth requesting. The decision point is simple: if there is a significant new diagnosis or hospitalization since the records were gathered, say so, because the underwriter cannot use what was never sent.

Decision Four: What Happens If You Outlive the Estimate

Nothing, from the seller’s side. Once a sale closes and escrow releases the funds, the transaction is done. The buyer bears the longevity risk entirely. You do not owe money back, you are not asked to repay anything, and no one has a claim on your estate. The number was the buyer’s bet, not your promise.

The practical consequence is different and worth naming. Because the buyer now owns the policy and pays the premiums, they generally have the right to contact you or a designated party periodically to confirm the insured is living – typically through a tracking service, on a schedule set out in the contract. Read that clause before closing so the calls are not a surprise years later. See what happens when someone outlives the estimate.

Terms It Is Confused With

Life expectancy report versus life expectancy provider. The report is the document; the provider is the firm. People use the phrases interchangeably and then cannot tell whether they have been given one report or two.

Life settlement provider. Entirely different role – a state-licensed entity that acquires the policy. Confusing the two is the most frequent mix-up on this topic. See what a settlement provider does.

Carrier underwriting. The insurance company’s assessment when the policy was issued, which produced your rate class or table rating. That was about whether to insure you and at what price. LE underwriting asks a narrower question about remaining months, using current records.

A Social Security period life table figure. A population average by age and sex. It says nothing about an individual with three chronic conditions, and it is not what buyers use.

A physician’s prognosis. A clinical judgment for treatment planning, not an actuarial distribution. A doctor saying “maybe two years” is not an LE report, and the two frequently disagree.

One last thing worth saying plainly: the seller does not choose the LE provider, does not pay for the report – the cost, commonly a few hundred dollars per report, is borne by the buyer or broker – and cannot negotiate the estimate. Your only real leverage is the completeness of the records and the fees you agree to pay. That is worth knowing before anyone tells you otherwise. Start with what health conditions matter to a settlement if you are early in the process.

Frequently Asked Questions

Do I pay for the life expectancy report?

Normally no. The cost, commonly a few hundred dollars per report, is borne by the buyer or the broker as part of underwriting the file. If someone asks you to pay upfront for a life expectancy report as a condition of getting a quote, treat that as a warning sign and ask exactly what the fee covers before agreeing to anything.

Can I choose which LE firm reviews my records?

No. The buying side selects the firms, and the seller has no say. What you can control is the completeness of the records that get reviewed, which genuinely matters, and you can ask afterward how many reports were ordered, which firms produced them, and which figure the offer was priced from.

What does a mortality multiplier of 200 percent mean?

It means the underwriter assesses the insured as roughly twice as likely to die in a given period as the standard population of the same age and sex in the base mortality table, commonly a Society of Actuaries Valuation Basic Table. Buyers model from that curve rather than from the headline month figure, because it produces month-by-month probabilities.

Will I owe money if I live longer than the estimate?

No. Once the sale closes and escrow releases, the transaction is final and the buyer carries all of the longevity risk. There is no clawback and no claim against your estate. The buyer will generally have a contractual right to periodic contact to confirm the insured is living, which is worth reading before closing.

Does an LE report affect my insurance coverage?

No. The report is prepared for the secondary market and is not shared with your carrier in a way that changes an in-force policy. Your rate class was fixed when the policy was issued and cannot be reopened because of an LE review. The report also has no effect on health insurance or Medicare.

My doctor said two years. Why did the report say seven?

They answer different questions with different methods. A physician gives a clinical judgment for treatment planning, usually about a specific condition. An LE underwriter builds an actuarial distribution across the whole medical picture, including everything that is stable or well controlled. Disagreements are common, and the underwriter’s file is only as good as the records supplied.

Find out what your policy is worth — free, confidential, no obligation.

A 15-minute educational review covers your eligibility, every alternative, and a realistic view of what each path would net you.

Call (732) 978-9575 · Request a review online →

Table of Contents